Rasagiline Mesylate 1 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 1 mg
Reference Brands: Azilect (USA),
Category: Neurology
Rasagiline Mesylate is a Neurology product available as Tablets in strengths 1 mg. It corresponds to the reference brands Azilect (USA),. Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Rasagiline is a selective monoamine oxidase-B (MAO-B) inhibitor widely used in the management of Parkinson’s disease. It is prescribed as monotherapy in the early stages of Parkinson’s disease to help control symptoms such as tremor, rigidity, and slowness of movement, and as an adjunct therapy in more advanced stages alongside levodopa to reduce motor fluctuations and “off” episodes. By inhibiting the breakdown of dopamine in the brain, rasagiline increases and prolongs dopamine activity, which is essential for improving motor control in patients with Parkinson’s disease.
In addition to its benefits on motor symptoms, rasagiline has demonstrated effectiveness in addressing certain non-motor symptoms of Parkinson’s disease, including fatigue, which can significantly impact quality of life. Its once-daily oral dosing and favorable tolerability profile make it a convenient and well-accepted option for long-term therapy. Clinical studies such as the TEMPO and ADAGIO trials explored the potential disease-modifying effects of rasagiline; however, regulatory authorities concluded that available evidence supports its role as a symptomatic treatment rather than a proven neuroprotective therapy. Overall, rasagiline remains an important and established treatment option in both early and advanced Parkinson’s disease management.
Rasagiline Mesylate — third party manufacturing & bulk supply
Rasagiline Mesylate 1 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Rasagiline Mesylate is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Rasagiline Mesylate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Rasagiline Mesylate →Frequently Asked Questions
Rasagiline mesylate is used for the treatment of Parkinson’s disease. It is prescribed as monotherapy in early-stage Parkinson’s disease or as an add-on treatment with levodopa in advanced stages to reduce motor fluctuations and improve symptoms such as tremor, stiffness, and slowed movement.
Rasagiline mesylate is made from rasagiline, a synthetic selective monoamine oxidase-B (MAO-B) inhibitor, formulated as a mesylate salt to improve stability and bioavailability. It works by preventing the breakdown of dopamine in the brain.
The trade name of rasagiline mesylate is Azilect. It is also available globally under various generic rasagiline brands.
The branded product Azilect is manufactured by Teva Pharmaceutical Industries. Generic versions are produced by multiple pharmaceutical manufacturers worldwide.
The generic name of the product is rasagiline mesylate.
The brand name of rasagiline mesylate is Azilect.
Rasagiline mesylate is manufactured in different countries depending on the manufacturer, including the USA, EU member states, Israel, and India, following international regulatory and quality standards.
Related Products
Valproic Acid
Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
View Details
Quick Response Guaranteed | Verified Suppliers
